UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions

Circulation (New York, N.Y.), 2006-05, Vol.113 (20), p.2462-2472

CHAITMAN, Bernard R

2006

Volltextzugriff (PDF)

Fourth Universal Definition of Myocardial Infarction (2018)

Circulation (New York, N.Y.), 2018-11, Vol.138 (20), p.e618-e651

2018

Volltextzugriff (PDF)

Troponin and Cardiac Events in Stable Ischemic Heart Disease and Diabetes

The New England journal of medicine, 2015-08, Vol.373 (7), p.610-620

2015

Volltextzugriff (PDF)

An electrocardiogram should not be included in routine preparticipation screening of young athletes

Circulation (New York, N.Y.), 2007-11, Vol.116 (22), p.2610-2615

Chaitman, Bernard R

2007

Volltextzugriff (PDF)

Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy

The New England journal of medicine, 2011-12, Vol.365 (24), p.2255-2267

2011

Volltextzugriff (PDF)

Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity

Circulation (New York, N.Y.), 2021-09, Vol.144 (13), p.1024-1038

2021

Volltextzugriff (PDF)

Exaggerated exercise-induced sytolic blood pressure response: arterial baroreceptor sensitivity or carotid stiffness?

European heart journal, 2018-02, Vol.39 (7), p.607-609

Chaitman, Bernard R

2018

Volltextzugriff (PDF)

Fourth Universal Definition of Myocardial Infarction (2018)

Global heart, 2018-12, Vol.13 (4), p.305-338

2018

Volltextzugriff (PDF)

Liberal or Restrictive Transfusion in High-Risk Patients after Hip Surgery

The New England journal of medicine, 2011-12, Vol.365 (26), p.2453-2462

2011

Volltextzugriff (PDF)

Liberal versus restrictive blood transfusion strategy: 3-year survival and cause of death results from the FOCUS randomised controlled trial

The Lancet (British edition), 2015-03, Vol.385 (9974), p.1183-1189

2015

Volltextzugriff (PDF)

2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards)

Journal of the American College of Cardiology, 2015-07, Vol.66 (4), p.403-469

2015

Volltextzugriff (PDF)

Evaluation of Ranolazine in Patients With Type 2 Diabetes Mellitus and Chronic Stable Angina

Journal of the American College of Cardiology, 2013-05, Vol.61 (20), p.2038-2045

2013

Volltextzugriff (PDF)

Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome

The New England journal of medicine, 2012-11, Vol.367 (22), p.2089-2099

2012

Volltextzugriff (PDF)

Effect of PCI on Long-Term Survival in Patients with Stable Ischemic Heart Disease

The New England journal of medicine, 2015-11, Vol.373 (20), p.1937-1946

2015

Volltextzugriff (PDF)

Is the 99th Percentile the Optimal Reference Limit to Diagnose Myocardial Infarction With High-Sensitivity Cardiac Troponin Assays in Patients With Chronic Kidney Disease?

Circulation (New York, N.Y.), 2015-06, Vol.131 (23), p.2029-2031

Chaitman, Bernard R

2015

Volltextzugriff (PDF)

Response by Chaitman et al to Letter Regarding Article, "Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons"

Circulation (New York, N.Y.), 2021-07, Vol.144 (2), p.e14-e15

2021

Volltextzugriff (PDF)

Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons

Circulation (New York, N.Y.), 2021-02, Vol.143 (8), p.790-804

2021

Volltextzugriff (PDF)

Rationale and design of the Women's Ischemia Trial to Reduce Events in Nonobstructive CAD (WARRIOR) trial

The American heart journal, 2021-07, Vol.237, p.90-103

2021

Volltextzugriff (PDF)

Initiating PCSK9 Inhibition in Hospital for ACS: We Can, But Does That Mean We Should?

Journal of the American College of Cardiology, 2019-11, Vol.74 (20), p.2463-2465

2019

Volltextzugriff (PDF)

Evaluation of Ranolazine in Patients With Type 2 Diabetes Mellitus and Chronic Stable Angina: Results From the TERISA Randomized Clinical Trial (Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina)

Journal of the American College of Cardiology, 2013-05, Vol.61 (20), p.2038-2045

2013

Volltextzugriff (PDF)

A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease

The New England journal of medicine, 2009-06, Vol.360 (24), p.2503-2515

2009

Volltextzugriff (PDF)

2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards)

Circulation (New York, N.Y.), 2015-07, Vol.132 (4), p.302-361

2015

Volltextzugriff (PDF)

Assessment of the 12-lead electrocardiogram as a screening test for detection of cardiovascular disease in healthy general populations of young people (12-25 years of age): a scientific statement from the American Heart Association and the American College of Cardiology

Journal of the American College of Cardiology, 2014-10, Vol.64 (14), p.1479-1514

2014

Volltextzugriff (PDF)

Health Status after Invasive or Conservative Care in Coronary and Advanced Kidney Disease

The New England journal of medicine, 2020-04, Vol.382 (17), p.1619-1628

2020

Volltextzugriff (PDF)

1 – 25 von 536

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(519)
Mit Volltextzugriff
(499)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(338)
Science & Technology
(326)
Life Sciences & Biomedicine
(325)
Cardiovascular System & Cardiology
(266)
Cardiac & Cardiovascular Systems
(264)
Male
(213)
Female
(209)
Biological And Medical Sciences
(199)
Medical Sciences
(199)
Middle Aged
(177)
Heart
(135)
Cardiology. Vascular System
(134)
Aged
(125)
Coronary Heart Disease
(110)
Electrocardiography
(91)
Adult
(75)
Prognosis
(71)
Exercise Test
(69)
Heart Attacks
(67)
Risk Factors
(63)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions

Fourth Universal Definition of Myocardial Infarction (2018)

Troponin and Cardiac Events in Stable Ischemic Heart Disease and Diabetes

An electrocardiogram should not be included in routine preparticipation screening of young athletes

Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy

Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity

Exaggerated exercise-induced sytolic blood pressure response: arterial baroreceptor sensitivity or carotid stiffness?

Fourth Universal Definition of Myocardial Infarction (2018)

Liberal or Restrictive Transfusion in High-Risk Patients after Hip Surgery

Liberal versus restrictive blood transfusion strategy: 3-year survival and cause of death results from the FOCUS randomised controlled trial

2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards)

Evaluation of Ranolazine in Patients With Type 2 Diabetes Mellitus and Chronic Stable Angina

Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome

Effect of PCI on Long-Term Survival in Patients with Stable Ischemic Heart Disease

Is the 99th Percentile the Optimal Reference Limit to Diagnose Myocardial Infarction With High-Sensitivity Cardiac Troponin Assays in Patients With Chronic Kidney Disease?

Response by Chaitman et al to Letter Regarding Article, "Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons"

Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons

Rationale and design of the Women's Ischemia Trial to Reduce Events in Nonobstructive CAD (WARRIOR) trial

Initiating PCSK9 Inhibition in Hospital for ACS: We Can, But Does That Mean We Should?

Evaluation of Ranolazine in Patients With Type 2 Diabetes Mellitus and Chronic Stable Angina: Results From the TERISA Randomized Clinical Trial (Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina)

A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease

2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards)

Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention

Assessment of the 12-lead electrocardiogram as a screening test for detection of cardiovascular disease in healthy general populations of young people (12-25 years of age): a scientific statement from the American Heart Association and the American College of Cardiology

Health Status after Invasive or Conservative Care in Coronary and Advanced Kidney Disease

Suchergebnisse filtern